NCT03726385 is a clinical trial in Cerebral Palsy, sponsored by Dilara Merve Sarı.

Who is sponsoring NCT03726385?

NCT03726385 is sponsored by Dilara Merve Sarı.

What condition does NCT03726385 study?

NCT03726385 studies Cerebral Palsy.

Is NCT03726385 still recruiting?

NCT03726385 is currently completed. Last updated 31 October 2018.

Last reviewed 2018-10-31 · How we verify

NCT03726385

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of the Effectiveness of Visual Feedback Training on Upper Extremity Functions in Cerebral Palsy

Completed Last updated 31 October 2018

What this trial tests

trial in Cerebral Palsy in 38 participants. Completed in 1 June 2018.

Timeline

8 January 2018

Primary endpoint
21 May 2018

1 June 2018

Quick facts

Lead sponsor	Dilara Merve Sarı
Status	Completed
Study type	OBSERVATIONAL
Enrollment	38
Start date	8 January 2018
Primary completion	21 May 2018
Estimated completion	1 June 2018
Sites	1 location across Turkey (Türkiye)

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →

Sponsor

Dilara Merve Sarı

Who can join

Adults 4 to 18, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study was to investigate the effectiveness of Cogniboard® Light Trainer, an education device with visual feedback that is added to the Neurodevelopmental Therapy Method (NDT) based upper extremity rehabilitation in children with cerebral palsy, on upper extremity functions such as joint range of motion (ROM), muscle tone, grip strength, pinch strength and functional abilities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03726385 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dilara Merve Sarı
Last refreshed: 31 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03726385.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing